Vascular Grafts Market is expected to grow at a CAGR of 6.86% by 2032, estimates DelveInsight

The global vascular grafts market was estimated at USD 1,863.09 million in 2024 and is projected to grow at a CAGR of 6.86% from 2025 to 2032, reaching approximately USD 3,153.39 million by 2032. Market growth is being fueled by the rising prevalence of cardiovascular diseases and related risk factors, including hypertension, diabetes, and obesity, which are increasing the need for surgical interventions. Furthermore, growing awareness and the expansion of cardiovascular screening programs are enabling earlier detection and timely treatment, thereby driving the demand for vascular grafts.

DelveInsight's Vascular Grafts Market Insights report provides the current and forecast market analysis, individual leading Vascular Grafts companies' market shares, challenges, Vascular Grafts market drivers, barriers, and trends, and key Vascular Grafts companies in the market.

Request for a sample page report @ https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Vascular Grafts Market Report
The Vascular Grafts market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Vascular Grafts market during the forecast period.
Notable Vascular Grafts companies such as BD, Getinge AB, Medtronic plc., B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, Healionics, and several others are currently operating in the Vascular Grafts market.
In November 2024, Healionics was granted FDA Breakthrough Device designation for its StargraftTM arteriovenous graft, designed to enhance dialysis access outcomes by lowering the risks of infection and thrombosis.
In January 2024, W. L. Gore & Associates secured FDA approval for the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE), marking the first off-the-shelf endovascular graft developed for treating complex aneurysmal disease affecting the visceral aorta.

To read more about the latest highlights related to the Vascular Grafts market, get a snapshot of the key highlights entailed in the Global Vascular Grafts Market Report https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Vascular Grafts Overview

Vascular grafts are surgical implants used to replace, repair, or bypass damaged or diseased blood vessels to restore normal blood circulation. They are commonly utilized in the management of cardiovascular conditions such as aortic aneurysms, peripheral artery disease, coronary artery disease, and complications related to dialysis access.

These grafts can be synthetic (made from materials such as ePTFE or Dacron) or biological (derived from human or animal tissues), with the choice depending on the clinical requirement and patient condition. In recent years, endovascular techniques such as stent grafting have gained prominence, offering less invasive alternatives to open surgery with quicker recovery times.

The growing global burden of cardiovascular diseases, combined with risk factors such as diabetes, hypertension, obesity, and aging populations, is significantly driving demand for vascular grafts. Moreover, advancements in graft design, materials, and minimally invasive technologies, along with increasing awareness and screening programs for cardiovascular health, are further supporting market expansion.

Vascular Grafts Market Insights

North America is projected to hold the largest share of the vascular grafts market in 2024, supported by multiple factors. The region records a high prevalence of vascular diseases, benefits from a well-developed healthcare infrastructure, and demonstrates broad adoption of advanced surgical approaches such as endovascular repair. Additionally, the strong presence of leading medical device manufacturers, higher healthcare expenditure, and favorable reimbursement frameworks further strengthen the market. Rising awareness of early detection and treatment for conditions such as abdominal aortic aneurysms, coupled with a rapidly aging population, continues to reinforce North America's dominant position.

According to the Centers for Disease Control and Prevention (2024), around 4.9% of U.S. adults were diagnosed with coronary heart disease in 2022. By 2023, an estimated 12.1 million Americans were projected to be living with atrial fibrillation. Each year, more than 795,000 people in the U.S. suffer a stroke, with roughly 610,000 being first-time cases and about 185,000 recurrent strokes. These conditions, often linked to blood clots obstructing cerebral circulation, can result in long-term vascular damage requiring surgical interventions such as graft implantation. With aging populations and lifestyle-related risk factors-including diabetes, hypertension, and obesity-continuing to rise, the demand for both synthetic and biological vascular grafts is expected to grow significantly.

To know more about why North America is leading the market growth in the Vascular Grafts market, get a snapshot of the Vascular Grafts Market Outlook https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Vascular Grafts Market Dynamics

According to the British Heart Foundation (2025), nearly 640 million people worldwide are living with heart and circulatory diseases. Further, data from 2024 revealed that coronary (ischemic) heart disease, the most prevalent form globally, impacts around 200 million people, including 110 million men and 80 million women. Additionally, approximately 56 million women and 45 million men are stroke survivors. It is also estimated that over 13 million individuals live with congenital heart disease, with many more cases likely undiagnosed. These conditions often cause damage or blockages in blood vessels, necessitating surgical interventions where vascular grafts-either synthetic or biological-are used to repair, replace, or bypass affected vessels, thereby fueling market growth.

Moreover, rising awareness initiatives for cardiovascular health are playing a crucial role in early detection, preventive care, and timely treatment. For instance, World Heart Day, organized annually by the World Heart Federation, promotes global awareness about cardiovascular diseases, prevention measures, and the importance of early diagnosis. Such campaigns encourage screening and treatment, including surgical interventions using vascular grafts, ultimately driving demand in the vascular grafts market.

Vascular Grafts Market Drivers:
Rising cases of cardiovascular disorders and associated risk factors
Increasing awareness and screening programs
Increase in product development activities among the key market players across the globe

Get a sneak peek at the Vascular Grafts market dynamics @ https://www.delveinsight.com/sample-request/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Scope of the Vascular Grafts Market Report:
Coverage: Global
Study Period: 2022 to 2032
Key Vascular Grafts Companies: BD, Getinge AB, Medtronic plc., B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, W. L. Gore & Associates, Inc., JOTEC GmbH, LeMaitre Vascular, Inc., Perouse Medical, CryoLife, Inc, BIOVIC Sdn Bhd, Abbott, Bentley, BioIntegral Surgical, Cook, Merit Medical Systems, SCITECH., Vascular Graft Solutions, Healionics, and others.

Which MedTech key players in the Vascular Grafts market are set to emerge as the trendsetter, explore @ Vascular Grafts Companies https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Trending Reports By DelveInsight:

Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market

Leber's Hereditary Optic Neuropathy Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market

Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market

Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market

Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market

Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market

Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market

Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market

Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market

Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market

Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market

Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market

Hypoplastic Left Heart Syndrome Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market

Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market

Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market

Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market

Clinically Isolated Syndrome Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market

Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market

Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market

Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market

Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market

Contact Info:

Kritika Rehani
Assistant Manager, Digital Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
www.delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.